Readers may recall the plight of Amanda Twellman-Dieppa, who fought to gain access to clinical trials for the experimental drug ‘MDX-60’, which was in phase II clinical trials, and was not planning to take additional patients.
The Medarex company graciously added Amanda to their trials, and hope was high for good results. The treatments began on May 25th.
I am saddened to say that, although the drug did not produce any malignant effects, Amanda contracted pneumonia around the first of July, and passed away the evening of July 19. More information on Amanda's final days may be found here.
Jeffrey King wrote what amounts to a brief and poignant obituary, finishing with an appropriate request:
“Please pray for her family, her friends, and her husband Aaron”
May the Lord indeed provide solace and comfort for the family, and for all such patients who fight for the health and life we so often take for granted.
(thanks to ThreeBadFingers for the information)